This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB07382/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07382/identifier/pubchem-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07382/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07382/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07382
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07382 n9:DB07382
dcterms:title
N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine
adms:identifier
n8:DB07382 n10:APJ n11:42627755 n12:99443853
n3:IUPAC-Name
n4:271B3F0B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3F11-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3F10-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3F0D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3F0E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3F0F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3F09-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3F07-363D-11E5-9242-09173F13E4C5 n4:271B3F0A-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3F08-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3F17-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3F18-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3F12-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3F13-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3F15-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3F14-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3F16-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B3F1D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3F1F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3F20-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3F1C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3F1B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3F1E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3F0C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3F19-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3F1A-363D-11E5-9242-09173F13E4C5